Dietary docosahexaenoic acid alters pregnant rat reproductive tissue prostaglandin and matrix metalloproteinase production

Journal of Nutritional Biochemistry

Volumn 17, Issue 7, 2006, Pages 446-453

  Perez, Mark A ^a   Hansen, Rodney A ^b   Harris, Mary A ^a   Allen, Kenneth G D ^b  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b WEBER STATE UNIVERSITY   (United States)

Author keywords

Docosahexaenoic acid (DHA); Matrix metalloproteinases (MMPs); n 3 n 6 ratio; Pregnancy; Prostaglandins

Indexed keywords

ARACHIDONIC ACID; COLLAGENASE; DOCOSAHEXAENOIC ACID; GELATINASE A; GELATINASE B; LINOLENIC ACID; MATRIX METALLOPROTEINASE; PROSTAGLANDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCEPTION; CONTROLLED STUDY; DIETARY INTAKE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; GENITAL SYSTEM; GESTATION PERIOD; NONHUMAN; PLACENTA; PREGNANCY; PREMATURE LABOR; PROSTAGLANDIN SYNTHESIS; RAT; UTERUS;

ALPHA-LINOLENIC ACID; ANIMALS; COLLAGENASES; DIETARY FATS, UNSATURATED; DOCOSAHEXAENOIC ACIDS; FEMALE; LINOLEIC ACID; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PLACENTA; PREGNANCY; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASE-2; UTERUS;

ANIMALIA;

EID: 33744998474     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2005.10.003     Document Type: Article

References (52)

1. McCormack M.C. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 312 (1987) 82-90
2. Anonymous. Healthy People 2010: understanding and improving health. U.S. Department of Health and Human Services. 2nd ed. (2000), U.S. Government Printing Office, Washington (DC) 16-1-16-62. http://www.health.gov/healthypeople
3. Allen K.G.D., and Harris M.A. The role of n-3 fatty acids in gestation and parturition. Exp Biol Med 226 (2001) 498-506
4. Smuts C.M., Huang M., Mundy D., Plasse T., Major S., and Carlson S.E. A randomized trial of docosahexaenoic acid supplementation during the third semester of pregnancy. Obstet Gynecol 101 (2003) 469-479
5. Reece M.S., McGregor J.A., Allen K.G.D., Mathias M.M., and Harris M.A. Prostaglandins in selected reproductive tissues in pre-term and full term gestations. Prostaglandins Leukot Essent Fatty Acids 55 (1996) 303-307
6. Sadovsky Y., Nelson D.M., Muglia L.J., Gross G.A., Harris K.C., Koki A., et al. Effective diminution of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2. Am J Obstet Gynecol 182 (2000) 370-376
7. Reece M.S., McGregor J.A., Allen K.G.D., and Harris M.A. Maternal and perinatal long chain fatty acids: possible roles in preterm birth. Am J Obstet Gynecol 176 (1997) 907-914
8. Cawston T.E. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther 70 (1996) 163-182
9. Stamenkovic I. Extracellular matrix remodeling: the role of matrix metalloproteinases. J Pathol 200 (2003) 448-464
10. 2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J Biol Chem 267 (1992) 515-519
11. Mengshol J.A., Mix K.S., and Brinckerhoff C.E. Matrix metalloproteinases as therapeutic targets in arthritic diseases: bulls-eye or missing the target. Arthritis Rheum 46 (2002) 13-20
12. 2 synthesis. J Invest Dermatol 104 (1995) 52-57
13. Athayde N., Remero N., Gomez R., Maymon M., Pacora P., Mazor M., et al. Matrix metalloproteinase-9 in preterm and term human parturition. J Matern Fetal Med 8 (1999) 213-219
14. Locksmith G., Clark P., Duff R., and Schultz G.S. Amniotic fluid matrix metalloproteinase-9 levels in women with preterm labor and suspected intra-amniotic infection. Obstet Gynecol 94 (1999) 1-6
15. Kris-Etherton P.M., Taylor D.S., Yu-Poth S., Hurth P., Moriarty K., Fishell V., et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 71 (2000) 179S-188S
16. Brenna J.T. Efficiency of conversion of α-linolenic acid to long chain n-3 fatty acids in man. Curr Opin Clin Nutr Metab Care 5 (2002) 127-132
17. Pawlosky R.J., Hibblen J.R., Novotny J.A., and Salem N. Physiological compartment analysis of α-linolenic acid metabolism in adult humans. J Lipid Res 42 (2001) 1257-1265
18. Cho H.P., Nakamura M., and Clarke S.D. Cloning, expression, and fatty acid regulation of the human Δ-5 desaturase. J Biol Chem 274 (1999) 37335-37339
19. Cho H.P., Nakamura M., and Clarke S.D. Cloning, expression, and fatty acid regulation of the mammalian Δ-6 desaturase. J Biol Chem 274 (1999) 471-477
20. Harris M.A., and Kesel M.L. Improved method for accurately timed mating in rats. Lab Anim Sci 40 (1990) 424-425
21. Reeves P.G., Nielsen F.H., and Fahey G.C. AIN-93 purified diets for laboratory animal rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 123 (1993) 1939-1951
22. Steinberg L.Y., Mauldin R.E., and Mathias M.M. The effect of dietary lipids on clotting times and rat serum and urine prostaglandin concentrations. Prog Lipid Res 20 (1981) 485-489
23. Heussen C., and Dowdle E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102 (1980) 196-202
24. Roeb E., Dietrich C.G., Winograd R., Arndt M., Breuer B., Fass J., et al. Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9. Cancer 92 (2001) 2680-2691
25. Fujimoto N., Tokai H., Iwata K., Okada Y., and Hayakawa T. Determination of tissue inhibitor of metalloproteinases-2 (TIMP-2) in experimental animals using monoclonal antibodies against TIMP-2-specific oligopeptides. J Immunol Methods 187 (1995) 33-39
26. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72 (1976) 248-254
27. Harris M.A., Hansen R.A., Vidsudhipan P., Koslo J.L., Thomas J.B., Watkins B.A., et al. Effects of conjugated linoleic acids and docosahexaenoic acid on rat liver and reproductive tissue fatty acids, prostaglandins and matrix metalloproteinase production. Prostaglandins Leukot Essent Fatty Acids 65 (2001) 23-29
28. Willis A.L. Unanswered questions in EFA and PG research. Prog Lipid Res 20 (1981) 839-850
29. Emken E.A., Adlof R.O., and Gulley R.M. Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta 1213 (1994) 277-288
30. Mead J.F., and Willis A.L. The essential fatty acids: their derivation and role. CRC handbook of eicosanoids: prostaglandins and related lipids vol. 1 (1987), CRC Press, Boca Raton (Fla) 85-98 [Part A]
31. Muskiet F.A., Fokkema M.R., Schaafsma A., Boersma E.R., and Crawford M.A. Is docosahexaenoic acid (DHA) essential? Lessons from DHA status regulation, our ancient diet, epidemiology and randomized controlled trials. J Nutr 134 (2004) 183-186
32. Jones L.L., and Whelan J. Human equivalent dose modeling for omega-3 fatty acid supplementation in C57BL/6J mice. FASEB J 19 (2005) A1008 [abstract 590.3]
33. Kleiber M. Body size and metabolic rate. Physiol Rev 27 (1947) 511-541
34. Sprecher H. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta 1486 (2000) 219-231
35. Li D., Sinclair A., Wilson A., Nakkote S., Kelly F., Abedin L., et al. Effect of dietary α-linolenic acid on thrombotic risk factors in vegetarian men. Am J Clin Nutr 69 (1999) 872-882
36. Fokkema M.R., Brouwer D.A.J., Hasperhoven M.B., Martini I.A., and Muskiet F.A. Short-term supplementation of low-dose γ-linolenic (GLA), α-linolenic (ALA), or GLA plus ALA does not augment LCPω3 status of Dutch vegans to an appreciable extent. Prostaglandins Leukot Essent Fatty Acids 63 (2000) 287-292
37. Davis B.C., and Kris-Etherton P.M. Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications. Am J Clin Nutr 78 (2003) 640S-646S
38. Whelan J., and McEntee M.F. Dietary (n-6) PUFA and intestinal tumorigenesis. J Nutr 134 (2004) 3421S-3426S
39. Lee J.Y., Plakidas A., Lee W.H., Heikkinen A., Chanmugam P., Bray G., et al. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 44 (2003) 479-486
40. Rao C.V., Hirose Y., Indranie C., and Reddy B.S. Modulation of experimental colon tumorigenesis by type and amounts of fatty acids. Cancer Res 61 (2001) 1927-1933
41. Bagga D., Wang L., Farias-Eisner R., Glaspy J.A., and Reddy S.T. Differential effects of prostaglandins derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 100 (2003) 1751-1756
42. Zahner G., Harendza S., Muller E., Wolf G., Thaiss F., and Stahl R.A. Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells. Kidney Int 51 (1997) 1116-1123
43. 2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2. Cancer Res 64 (2004) 7439-7446
44. Callejas N.A., Casado M., Diaz-Guerra M.J., Bosca L., and Martin-Sanz P. Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes. Hepatology 33 (2001) 860-867
45. Lindsey J.D., Kashiwagi K., Boyle D., Kashiwagi F., Firestein G.S., and Weinreb R.N. Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary muscle cells. Curr Eye Res 15 (1996) 869-875
46. Faisal Kahn K.M., Howe L.R., and Falcone D.J. Extracellular matrix-induced cyclooxygenase-2 regulates macrophage proteinase expression. J Biol Chem 279 (2004) 22039-22046
47. 2α and indomethacin. Mol Hum Reprod 7 (2001) 1187-1193
48. Uchide K., Ueno H., Inoue M., Sakai A., Fujimoto N., and Okada Y. Matrix metalloproteinases-9 and tensile strength of fetal membranes in uncomplicated labor. Obstet Gynecol 95 (2000) 851-855
49. Athayde N., Edwin S.S., and Romero R. A role for matrix metalloproeinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol 179 (1998) 1248-1253
50. 2 dependent production of latent matrix metalloproteinase-9 in cultures of human fetal membranes. Mol Hum Reprod 6 (2000) 1033-1040
51. 2-cyclic adenosine monophosphate. Am J Obstet Gynecol 187 (2002) 202-208
52. Ma C., and Chegini N. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1. Mol Hum Reprod 5 (1999) 950-954